Details of CPPsite entry with Sequence GD(Abu)LPHLKLC |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | GD(Abu)LPHLKLC |
| CPPsite ID | 2329, |
| PEPTIDE NAME | MCa UF1-9-C-Cy5 |
| CHIRALITY | Modified |
| LINEAR/CYCLIC | Linear |
| SOURCE | Synthetic |
| CATEGORY | Cationic |
| SUB CELLULAR LOCALIZATION | Vesicles |
| N-TERMINAL MODIFICATION | Free |
| C-TERMINAL MODIFICATION | Cysteine addition |
| CHEMICAL MODIFICATION | Abu, isosteric 2-aminobutyric acid |
| UPTAKE EFFICIENCY | High uptake efficiency |
| PROPOSED UPTAKE MECHANISM | Endocytic pathway |
| INVITRO/INVIVO | In vitro |
| CELL LINE | Undifferentiated malignant glioma rat (F98) cell line, CHO cells |
| CARGO | Fluorophore (Cy5) |
| PMID | 24276021 |
| PATENT | Unknown |
| Tertiary Structure (Technique) | 2329 (PEPstrMOD), |